Developer docs
API playgroundTry for free, no card

Search company profiles

High Q Technologies

Full company profile

uuid0000lir

Namestring
High Q Technologies
Legal namestring
High Q Technologies Inc.
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWaterloo, Canada
HQ citystring
Waterloo
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electron paramagnetic resonance, quantum-enabled spectroscopy, protein dynamics analysis, structural biology instruments, drug discovery spectroscopy
Industry4 codes
PRIMARYHDAGAHAH
Quantum Spectroscopy & Chemical/Biological Sensing
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHDAGABAJ
Filters, Attenuators, Isolators & Circulators (Cryo-Compatible RF Components)
Hardware, Technology & Telecom/Quantum Computing/Quantum Control Electronics & Cryogenics
SECONDARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Other Measuring and Controlling Device Manufacturing334519
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Industrial Instruments For Measurement, Display, And Control3823
Product category
Scientific Instrumentation — Quantum-Enabled EPR Spectroscopy
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1FATHOM EPR Spectrometer Sales
TypeHardware Sales
Description

Sale of quantum-enabled EPR spectrometers to pharmaceutical companies, biotech firms, and academic institutions for in-house protein dynamics research. First commercial sale announced January 2025. Capital equipment purchase model.

highqtechnologies.com
2Sample Measurement Service (SMS)
TypeProfessional Services
Description

Contract research service where customers ship samples to High Q's applications lab. Team handles measurement and returns detailed reports with publication-quality data. Fully customizable experiments with rapid turnaround and IP protection.

highqtechnologies.com
3Accessories and Consumables
TypeHardware Sales
Description

Ongoing revenue from spin labels, sample cartridges, and other consumables required for FATHOM operation. Accessories and consumables listed as product category on website.

highqtechnologies.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Technology or R&D, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1FATHOM®
Description

The world's first quantum-enabled EPR spectrometer for protein dynamics analysis

highqtechnologies.com
+3 more records
Core offering1 text field

High Q Technologies designs, manufactures, and sells quantum-enabled Electron Paramagnetic Resonance (EPR) spectrometers — most notably the FATHOM® system — that measure protein conformational dynamics invisible to Cryo-EM, NMR, AlphaFold, and X-ray crystallography. The company supplements instrument sales with the DEEP™ analysis software, SQBA™ multi-sample consumable cartridges, and a Sample Measurement Service that performs EPR experiments on customer-supplied samples at the company's applications lab.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Acquisition time reduced from weeks to days for low-concentration samples
+2 more records
Product overview1 text field

High Q Technologies offers a unified product portfolio centered on quantum-enabled EPR spectroscopy for protein dynamics research. The core offering is FATHOM®, the world's first quantum-enabled EPR spectrometer, which is complemented by the DEEP™ analysis software and the SQBA™ multi-sample cartridge for automated workflow. For labs not ready to bring EPR in-house, the Sample Measurement Service provides outsourced access to the same quantum-enabled EPR technology. All products work together to enable structural biology and drug discovery researchers to access protein conformational dynamics that Cryo-EM, NMR, and AlphaFold cannot resolve.

Product and service3 records
1FATHOM® EPR Spectrometer
CategoryCore scientific instrument — quantum-enabled EPR spectrometer
Description

The world's first quantum-enabled Electron Paramagnetic Resonance spectrometer, combining a superconducting quantum-sensing resonator with proprietary quantum control algorithms to measure nanoscale protein distance distributions and conformational dynamics on micromolar samples in a few hours. Built for structural biology and drug discovery labs at pharmaceutical companies, biotech firms, and academic institutions.

2Sample Measurement Service (SMS)
CategoryContract research service
Description

Contract research service where researchers ship samples to High Q's applications lab; the team performs EPR measurements and returns detailed publication-quality reports. Provides labs that lack EPR expertise or capital budget with full access to quantum-enabled EPR data, with rapid turnaround and IP protection.

3SQBA™ Multi-Sample Cartridge
CategoryAccessory / consumable for FATHOM
Description

Proprietary consumable cartridge for the FATHOM spectrometer holding up to 5 samples with 3.5 µL each at micromolar concentrations, enabling efficient serial batch processing with full unattended operation and ongoing consumable revenue.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-02
Description

Strategic partnership announced June 2, 2026 to expand global access to quantum-enabled EPR spectroscopy for pharmaceutical and biotechnology research. Collaboration combines High Q's FATHOM EPR platform with Creative Biostructure's scientific consultation and workflow services. Partnership aims to overcome historical barriers to EPR adoption including instrument complexity and need for specialized technical expertise. Enables researchers to access EPR Sample Measurement Service through Creative Biostructure's broader structural biology service portfolio.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

High Q Technologies was born from research at IQC. Company's patented technologies are derived from advances in experimental quantum computing developed in collaboration with IQC researchers. IQC is a world-renowned center for quantum science and technology research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers7 records
TypeEmerging player
2JEOL
TypeDirect peer
Description

JEOL is a leading manufacturer of analytical instrumentation including EPR spectrometers, alongside NMR and mass spectrometry systems. As a direct peer in the EPR instrument category, JEOL serves the same pharmaceutical, academic, and government customers that High Q targets with FATHOM.

TypeEmerging player
Description

Quantum Machines provides quantum control electronics and orchestration systems used in quantum computing and adjacent quantum-sensing platforms. As an emerging player in quantum control hardware, it overlaps with High Q's quantum control algorithm and instrumentation stack from the enabling-technology side.

TypeOthers
Description

Cytiva (formerly GE Life Sciences) supplies tools and services across protein science and bioprocessing. While not a direct EPR competitor, Cytiva operates in overlapping protein characterization and drug discovery customer workflows where High Q's structural-biology users buy complementary tools.

TypeBroad incumbent
Description

Agilent provides analytical instruments and life-science tools used by pharma and academic customers, with overlapping presence in spectroscopy, chromatography, and structural biology workflows. As a broad incumbent, Agilent represents a competitive alternative in customer capital budgets.

TypeBroad incumbent
Description

Bruker is the dominant incumbent in EPR, NMR, and adjacent structural-biology instrumentation, with deep pharma and academic installed bases and a global service network. High Q's Director of Sales previously spent 25 years at Bruker BioSpin, underscoring the direct competitive overlap and channel relationships in EPR.

TypeBroad incumbent
Description

Thermo Fisher Scientific is the largest life-sciences instrumentation company, with broad portfolios in mass spectrometry, NMR-adjacent workflows, and structural-biology tools. High Q's VP of Sales previously spent 25 years at Thermo Fisher, reflecting deep incumbency overlap in the same customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

High Q Technologies

Scientific Instrumentation — Quantum-Enabled EPR Spectroscopyhighqtechnologies.com

High Q Technologies firmographics

Firmographics
Name
High Q Technologies
Legal name
High Q Technologies Inc.
Website
https://highqtechnologies.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

High Q Technologies industry classification

Industry
Product category
Scientific Instrumentation — Quantum-Enabled EPR Spectroscopy
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Other Measuring and Controlling Device Manufacturing (334519)
SIC
Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)
akta.pro industry
PRIMARYHDAGAHAH
Quantum Spectroscopy & Chemical/Biological Sensing
SECONDARYHLAGAIAB
Mass Spectrometry & Spectroscopy Instruments
SECONDARYHDAGABAJ
Filters, Attenuators, Isolators & Circulators (Cryo-Compatible RF Components)
Hardware, Technology & Telecom/Quantum Computing/Quantum Control Electronics & Cryogenics
SECONDARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)

Keywords

  • Electron paramagnetic resonance
  • Quantum-enabled spectroscopy
  • Protein dynamics analysis
  • Structural biology instruments
  • Drug discovery spectroscopy

Where High Q Technologies is headquartered

Location

Headquarters

HQ city
Waterloo
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

High Q Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel

Revenue model

  1. FATHOM EPR Spectrometer Sales: Sale of quantum-enabled EPR spectrometers to pharmaceutical companies, biotech firms, and academic institutions for in-house protein dynamics research. First commercial sale announced January 2025. Capital equipment purchase model.
  2. Sample Measurement Service (SMS): Contract research service where customers ship samples to High Q's applications lab. Team handles measurement and returns detailed reports with publication-quality data. Fully customizable experiments with rapid turnaround and IP protection.
  3. Accessories and Consumables: Ongoing revenue from spin labels, sample cartridges, and other consumables required for FATHOM operation. Accessories and consumables listed as product category on website.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

High Q Technologies product offering

Product offering

Core offering

High Q Technologies designs, manufactures, and sells quantum-enabled Electron Paramagnetic Resonance (EPR) spectrometers — most notably the FATHOM® system — that measure protein conformational dynamics invisible to Cryo-EM, NMR, AlphaFold, and X-ray crystallography. The company supplements instrument sales with the DEEP™ analysis software, SQBA™ multi-sample consumable cartridges, and a Sample Measurement Service that performs EPR experiments on customer-supplied samples at the company's applications lab.

Product overview

High Q Technologies offers a unified product portfolio centered on quantum-enabled EPR spectroscopy for protein dynamics research. The core offering is FATHOM®, the world's first quantum-enabled EPR spectrometer, which is complemented by the DEEP™ analysis software and the SQBA™ multi-sample cartridge for automated workflow. For labs not ready to bring EPR in-house, the Sample Measurement Service provides outsourced access to the same quantum-enabled EPR technology. All products work together to enable structural biology and drug discovery researchers to access protein conformational dynamics that Cryo-EM, NMR, and AlphaFold cannot resolve.

Differentiator

Problem solved

Functional benefit

Brands

  • FATHOM®: The world's first quantum-enabled EPR spectrometer for protein dynamics analysis
  • DEEP™
  • SQBA™
  • Sample Measurement Service

Products and services

  • FATHOM® EPR Spectrometer The world's first quantum-enabled Electron Paramagnetic Resonance spectrometer, combining a superconducting quantum-sensing resonator with proprietary quantum control algorithms to measure nanoscale protein distance distributions and conformational dynamics on micromolar samples in a few hours. Built for structural biology and drug discovery labs at pharmaceutical companies, biotech firms, and academic institutions.
  • Sample Measurement Service (SMS) Contract research service where researchers ship samples to High Q's applications lab; the team performs EPR measurements and returns detailed publication-quality reports. Provides labs that lack EPR expertise or capital budget with full access to quantum-enabled EPR data, with rapid turnaround and IP protection.
  • SQBA™ Multi-Sample Cartridge Proprietary consumable cartridge for the FATHOM spectrometer holding up to 5 samples with 3.5 µL each at micromolar concentrations, enabling efficient serial batch processing with full unattended operation and ongoing consumable revenue.

Quantifiable outcome

  • Acquisition time reduced from weeks to days for low-concentration samples
  • +2 more outcomes

Companies that use High Q Technologies

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

High Q Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

High Q Technologies partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Creative BiostructurecoreChannel Partner/ Reseller/ Distributor · 2 June 2026Strategic partnership announced June 2, 2026 to expand global access to quantum-enabled EPR spectroscopy for pharmaceutical and biotechnology research. Collaboration combines High Q's FATHOM EPR platform with Creative Biostructure's scientific consultation and workflow services. Partnership aims to overcome historical barriers to EPR adoption including instrument complexity and need for specialized technical expertise. Enables researchers to access EPR Sample Measurement Service through Creative Biostructure's broader structural biology service portfolio.
  • University of Waterloo - Institute for Quantum Computing (IQC)coreStrategic or Co-development PartnerHigh Q Technologies was born from research at IQC. Company's patented technologies are derived from advances in experimental quantum computing developed in collaboration with IQC researchers. IQC is a world-renowned center for quantum science and technology research.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

High Q Technologies competitors and assessment

Company assessment

Emerging players

  • Zurich Instruments:
  • Quantum Machines: Quantum Machines provides quantum control electronics and orchestration systems used in quantum computing and adjacent quantum-sensing platforms. As an emerging player in quantum control hardware, it overlaps with High Q's quantum control algorithm and instrumentation stack from the enabling-technology side.

Direct peers

  • JEOL: JEOL is a leading manufacturer of analytical instrumentation including EPR spectrometers, alongside NMR and mass spectrometry systems. As a direct peer in the EPR instrument category, JEOL serves the same pharmaceutical, academic, and government customers that High Q targets with FATHOM.

Others

  • Cytiva: Cytiva (formerly GE Life Sciences) supplies tools and services across protein science and bioprocessing. While not a direct EPR competitor, Cytiva operates in overlapping protein characterization and drug discovery customer workflows where High Q's structural-biology users buy complementary tools.

Broad incumbents

  • Agilent Technologies: Agilent provides analytical instruments and life-science tools used by pharma and academic customers, with overlapping presence in spectroscopy, chromatography, and structural biology workflows. As a broad incumbent, Agilent represents a competitive alternative in customer capital budgets.
  • Bruker BioSpin: Bruker is the dominant incumbent in EPR, NMR, and adjacent structural-biology instrumentation, with deep pharma and academic installed bases and a global service network. High Q's Director of Sales previously spent 25 years at Bruker BioSpin, underscoring the direct competitive overlap and channel relationships in EPR.
  • Thermo Fisher Scientific: Thermo Fisher Scientific is the largest life-sciences instrumentation company, with broad portfolios in mass spectrometry, NMR-adjacent workflows, and structural-biology tools. High Q's VP of Sales previously spent 25 years at Thermo Fisher, reflecting deep incumbency overlap in the same customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

High Q Technologies social profiles

Digital presence

High Q Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

High Q Technologies leadership team

Management profile

Number of profiles

Profiles8 records

High Q Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

High Q Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about High Q Technologies

What does High Q Technologies do?

High Q Technologies designs, manufactures, and sells quantum-enabled Electron Paramagnetic Resonance (EPR) spectrometers — most notably the FATHOM® system — that measure protein conformational dynamics invisible to Cryo-EM, NMR, AlphaFold, and X-ray crystallography. The company supplements instrument sales with the DEEP™ analysis software, SQBA™ multi-sample consumable cartridges, and a Sample Measurement Service that performs EPR experiments on customer-supplied samples at the company's applications lab.

Is High Q Technologies a public or private company?

High Q Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was High Q Technologies founded?

High Q Technologies was founded in 2013. It employs 11 to 50 people.

Where is High Q Technologies based?

High Q Technologies is headquartered in Waterloo, Canada, in the North America region.

How does High Q Technologies make money?

Three revenue lines are on record. FATHOM EPR Spectrometer Sales are the primary driver. The others are sample Measurement Service (SMS) and accessories and Consumables.

Who are High Q Technologies's main competitors?

Emerging players on record are Zurich Instruments and Quantum Machines. JEOL is listed as a direct peer. Cytiva is listed as an others. Broad incumbents are Agilent Technologies, Bruker BioSpin and Thermo Fisher Scientific.

Does High Q Technologies have an API?

No public API is recorded for High Q Technologies.

What industry is High Q Technologies in?

High Q Technologies's product category is Scientific Instrumentation — Quantum-Enabled EPR Spectroscopy. Its primary akta.pro industry code is HDAGAHAH, Quantum Spectroscopy & Chemical/Biological Sensing, with a secondary code of HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CalgaryheraldOntario startup aims to speed up drug discovery for diseases such as Alzheimer’s through quantum sensorsOntario startup High Q Technologies is developing a quantum sensor called Fathom to map moving protein structures with extreme precision. The device aims to accelerate drug discovery for neurodegenerative diseases like Alzheimer's by years and reduce testing resources. The company expects to ship the machine to Europe within coming months.Financial PostHigh Q Technologies and Creative Biostructure Announce Strategic Partnership Expanding Global Access to Quantum-Enabled EPR SpectroscopyHigh Q Technologies and Creative Biostructure announced a strategic partnership to expand global access to quantum-enabled EPR spectroscopy for pharmaceutical and biotechnology research. The collaboration combines High Q's FATHOM® EPR platform with Creative Biostructure's scientific consultation and workflow services to overcome historical barriers to EPR adoption, including instrument complexity and the need for specialized technical expertise. The partnership aims to accelerate adoption of EPR spectroscopy for studying dynamic protein systems relevant to drug discovery.PR NewswireHIGH Q TECHNOLOGIES INTRODUCES EPR SAMPLE MEASUREMENT SERVICE TO ADVANCE PROTEIN STRUCTURE RESEARCHHigh Q Technologies, an EPR spectrometer manufacturer headquartered in Waterloo, Ontario, announced the launch of its High Q Sample Measurement Service for the structural biology community on September 16, 2025. The service allows researchers in academia and the pharmaceutical industry to analyze molecular dynamics and conformational probabilities in protein samples using High Q's FATHOM EPR systems, positioning the technology as a complement and screening tool for Cryo-EM and AI-driven systems such as AlphaFold. The company is responding to a declining NIH funding environment, where year-over-year research and development funding dropped by over USD $3.5 billion, positioning the service as an alternative for labs that cannot afford capital purchases for their own instruments, with sample collection scheduled to begin in Q4 2025.PR NewswireHigh Q Technologies Announces Commercial Availability and First Sale of the FATHOM™ EPR SpectrometerHigh Q Technologies announced the commercial availability and first sale of its FATHOM EPR Spectrometer, a quantum-enabled device for automated protein dynamics analysis and drug discovery research. The first system was sold to a research consortium led by Prof. Reza Dastvan at Saint Louis University School of Medicine, with delivery planned for Q3 2025. The spectrometer features automated calibration, measurement, and analysis capabilities with over 10X lower sample volume requirements compared to existing EPR systems.NewswireHigh Q Technologies Announces Commercial Availability and First Sale of the FATHOM™ EPR SpectrometerHigh Q Technologies announced the commercial availability and first sale of its FATHOM EPR Spectrometer, a quantum-based sensor designed for automated protein structure analysis. The instrument was sold to a research consortium led by Prof. Reza Dastvan at Saint Louis University School of Medicine, with system delivery scheduled for the third quarter of 2025.Pulse 2.0High Q Technologies: Innovative Life Sciences Company Secures $3.75 MillionHigh Q Technologies secured a $3.75 million investment from the Government of Canada through FedDev Ontario to support the commercialization of its quantum-enabled Electron Paramagnetic Resonance (EPR) Spectroscopy systems. This funding aims to accelerate drug discovery by helping researchers study protein dynamics for pharmaceutical and biotechnology applications. The company previously received $6.5 million in 2019 to support early research and development of these quantum sensor technologies.NewswireHIGH Q TECHNOLOGIES SECURES $3.75 MILLION FROM GOVERNMENT OF CANADA TO SUPPORT EXPANSION OF PROTEIN MEASUREMENT PLATFORM FOR DRUG DISCOVERYHigh Q Technologies secured a $3.75 million investment from the Government of Canada through FedDev Ontario's Regional Quantum Initiative to support the commercialization of its quantum-enabled Electron Paramagnetic Resonance (EPR) Spectroscopy systems. This funding will facilitate product development and global beta testing for tools designed to characterize protein dynamics in drug discovery applications. The company plans to launch its first system this year, building upon previous government R&D support received in 2019.PR NewswireHIGH Q TECHNOLOGIES SECURES $3.75 MILLION FROM GOVERNMENT OF CANADA TO SUPPORT EXPANSION OF PROTEIN MEASUREMENT PLATFORM FOR DRUG DISCOVERYHigh Q Technologies Inc. has secured a $3.75 million investment from the Government of Canada through FedDev Ontario to support the commercialization of its Electron Paramagnetic Resonance (EPR) Spectroscopy systems for drug discovery. The funding, part of the Regional Quantum Initiative, will facilitate product development and global beta testing as the company prepares to launch its first system this year.GlobeNewswireHigh Q Technologies Inc. Hires Vice President, Research and Development and Announces Additional Recent Appointments to Support Rapid GrowthHigh Q Technologies appointed Andrew Wiles as Vice President of Research and Development, reporting to CEO Wendy Hinchey. Wiles brings over 20 years of product development experience, including a prior role at NDI. The company is preparing for the launch of its first commercial product.